Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pertagen 2-Dose vs 1-Dose Immunogenicity Study in Young Adults
NCT05193734Phase 3Unknown
- Start
- Feb 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paracetamol + caffeine in pertussis. Status: unknown.
02
Drugs
paracetamol + caffeine
03
Conditions
pertussis
Beyond the preview
Go deeper on NCT05193734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05193734.